You are here

  • Home
  • Archive
  • Volume 13, Issue 3
  • Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy

Article metrics

Article menu
Download PDFPDF
Original Articles
Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy

 

Online download statistics by month:

Online download statistics by month: February 2019 to April 2024

AbstractFullPdf
Feb 2019601
May 20191100
Jun 2019200
Jul 2019400
Aug 2019300
Sep 2019200
Oct 2019200
Nov 2019200
Dec 2019600
Jan 20201000
Feb 2020600
Mar 2020201
Apr 2020300
May 20201000
Jun 2020600
Jul 2020600
Aug 2020200
Sep 2020602
Oct 2020700
Nov 2020500
Dec 2020800
Jan 2021700
May 2021400
Jul 2021100
Oct 20211000
Nov 2021400
Dec 2021600
Jan 20221200
Feb 20221000
Mar 20221601
Apr 20221400
May 20223600
Jun 20223200
Jul 20221000
Aug 20223601
Sep 20223601
Oct 20224001
Nov 20221000
Dec 20221200
Jan 2023400
Feb 20236400
Mar 2023400
May 20231001
Jun 2023200
Jul 2023400
Aug 2023400
Sep 2023601
Oct 2023900
Nov 20231600
Dec 20231200
Jan 2024600
Feb 2024400
Mar 2024200
Apr 20241100
Total563010